Literature DB >> 10945490

Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma.

M Raderer1, F Vorbeck, M Formanek, C Osterreicher, J Valencak, M Penz, G Kornek, G Hamilton, B Dragosics, A Chott.   

Abstract

Lymphoma of the mucosa-associated lymphoid tissue (MALT) type usually arises in MALT acquired through chronic antigenic stimulation triggered by persistent infection and/or autoimmune processes. Due to specific ligand-receptor interactions between lymphoid cells and high-endothelial venules of MALT, both normal and neoplastic lymphoid cells display a pronounced homing tendency to MALT throughout the body. In the case of neoplastic disease these homing properties may be responsible for lymphoma dissemination among various MALT-sites. According to this concept, we have standardized staging procedures in all patients diagnosed with MALT-type lymphoma. All patients with MALT-type lymphoma underwent standardized staging procedures before treatment. Staging included ophthalmologic examination, otolaryngologic investigation, gastroscopy with multiple biopsies, endosonography of the upper gastrointestinal tract, enteroclysis, colonoscopy, computed tomography of thorax and abdomen and bone marrow biopsy. Biopsy was performed in all lesions suggestive for lymphomatous involvement, and evaluation of all biopsy specimens was performed by a reference pathologist. 35 consecutive patients with histologically verified MALT-type lymphoma were admitted to our department. Twenty-four patients (68%) had primary involvement of the stomach, five (15%) had lymphoma of the ocular adnexa, three (8.5%) had lymphoma of the parotid, and three (8,5%) of the lung. Lymph-node involvement corresponding to stage EII disease was found in 13 patients (37%), only one patient with primary gastric lymphoma had local and supradiaphragmatic lymph-node involvement (stage EIII). Bone marrow biopsies were negative in all patients. Overall, eight of 35 patients (23%) had simultaneous biopsy-proven involvement of two MALT-sites: one patient each had lymphoma of parotid and lacrimal gland, conjunctiva and hypopharynx, conjunctiva and skin, lacrimal gland and lung, stomach and colon, and stomach and lung. The remaining two patients had bilateral parotideal lymphoma. Staging work-up was negative for lymph-node involvement in all of these eight patients. The importance of extensive staging in MALT-type lymphoma is emphasized by the demonstration of multiorgan involvement in almost a quarter of patients. In addition, our data suggest that extra-gastrointestinal MALT-type lymphoma more frequently occurs simultaneously at different anatomic sites than MALT-type lymphoma involving the GI-tract.

Entities:  

Mesh:

Year:  2000        PMID: 10945490      PMCID: PMC2374656          DOI: 10.1054/bjoc.2000.1308

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

Authors:  C Berlin; E L Berg; M J Briskin; D P Andrew; P J Kilshaw; B Holzmann; I L Weissman; A Hamann; E C Butcher
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

2.  Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients.

Authors:  C Thieblemont; Y Bastion; F Berger; C Rieux; G Salles; C Dumontet; P Felman; B Coiffier
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

3.  Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy.

Authors:  N Haim; M Leviov; Y Ben-Arieh; R Epelbaum; N Freidin; R Reshef; M Ben-Shahar
Journal:  Leuk Lymphoma       Date:  1995-04

4.  [Clinical staging classification of non-Hodgkin's lymphomas (author's transl)].

Authors:  K Musshoff
Journal:  Strahlentherapie       Date:  1977-04

Review 5.  Gastric MALT lymphoma: from concept to cure.

Authors:  P G Isaacson
Journal:  Ann Oncol       Date:  1999-06       Impact factor: 32.976

6.  Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis.

Authors:  A Greiner; A Marx; J Heesemann; J Leebmann; B Schmausser; H K Müller-Hermelink
Journal:  Lab Invest       Date:  1994-04       Impact factor: 5.662

7.  Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue.

Authors:  E Roggero; E Zucca; G Pinotti; A Pascarella; C Capella; A Savio; E Pedrinis; A Paterlini; A Venco; F Cavalli
Journal:  Ann Intern Med       Date:  1995-05-15       Impact factor: 25.391

8.  Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma.

Authors:  Y Qin; A Greiner; M J Trunk; B Schmausser; M M Ott; H K Müller-Hermelink
Journal:  Blood       Date:  1995-11-01       Impact factor: 22.113

9.  Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease.

Authors:  A C Wotherspoon; C Doglioni; P G Isaacson
Journal:  Histopathology       Date:  1992-01       Impact factor: 5.087

10.  Determination of a common clonal origin of gastric and pulmonary mucosa-associated lymphoid tissue lymphomas presenting five years apart.

Authors:  N Kawamata; T Miki; T Fukuda; K Suzuki; Y Sumi; S Ohdama; S Hirosawa; O Matsubara; R Kamiyama; N Aoki
Journal:  Intern Med       Date:  1995-03       Impact factor: 1.271

View more
  34 in total

Review 1.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Sarah J Vinnicombe; Rodney H Reznek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

2.  Mucosa-associated Lymphoid Tissue Lymphoma of Colon: A Case Report and Literature Review of Rare Entity.

Authors:  Navroop Nagra; Ajeet R Singhvi; Gaurav Singhvi
Journal:  Cureus       Date:  2020-03-27

Review 3.  Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.

Authors:  M-Q Du; J C Atherton
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

4.  Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.

Authors:  Frédéric Charlotte; Kamal Doghmi; Nathalie Cassoux; Hongtao Ye; Ming-Qing Du; Michèle Kujas; Annette Lesot; George Mansour; Phuc Lehoang; Nicole Vignot; Frédérique Capron; Véronique Leblond
Journal:  Virchows Arch       Date:  2005-12-02       Impact factor: 4.064

5.  Marginal zone lymphoma of the lacrimal gland spreading to the lung and the bone marrow 11 years after first symptoms.

Authors:  Annette Zimpfer; Martin C Freund; Stephan Dirnhofer; Eberhard Gunsilius; Berthold Streubel; Andreas Chott; Alexandar Tzankov
Journal:  Virchows Arch       Date:  2005-11-17       Impact factor: 4.064

6.  Primary Orbital Follicular Lymphoma: A Case Report and Review.

Authors:  G Lakshmi Prasad; Ajay Hegde; Girish Menon; Mary Mathew
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial.

Authors:  Agustin Avilés; María Jesús Nambo; Natividad Neri; Alejandra Talavera; Sergio Cleto
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

8.  Mucosa-associated lymphoid tissue lymphoma of the esophagus coexistent with bronchus-associated lymphoid tissue lymphoma of the lung.

Authors:  Jae-Joon Chung; Myeong-Jin Kim; Jeong-Hae Kie; Ki Whang Kim
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

9.  MALT lymphoma in labial salivary gland biopsy from Sjögren syndrome: importance of follow-up in early detection.

Authors:  A Keszler; L I Adler; M S Gandolfo; P A Masquijo Bisio; A C Smith; C F Vollenweider; A M Heidenreich; G de Stefano; M V Kambo; D P Cox; M Narbaitz; H E Lanfranchi
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-11-13

10.  Sustained remissions with long-term weekly chlorambucil maintenance therapy in patients with mucosa-associated lymphoid tissue lymphoma.

Authors:  Arumugam Manoharan
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.